Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Nanjing Medlander Medical Technology Co's
Operating Income
for the
three
months ended in Mar. 2026 was ¥24.6 Mil. Nanjing Medlander Medical Technology Co's Interest Expense for the
three
months ended in Mar. 2026 was ¥-0.3 Mil.
Nanjing Medlander Medical Technology Co's interest coverage for the quarter that ended in Mar. 2026 was 79.78.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Nanjing Medlander Medical Technology Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
SHSE:688273'
s Interest Coverage Range Over the Past 10 Years
Min: 60.45 Med: 250.11 Max: 817.36
Current: 60.45
SHSE:688273's Interest Coverage is ranked better than 69.1% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs SHSE:688273: 60.45
Nanjing Medlander Medical Technology Co (SHSE:688273) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Nanjing Medlander Medical Technology Co Interest Coverage Related Terms
Nanjing Medlander Medical Technology Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Nanjing Medlander Medical Technology Co Interest Coverage Chart
Nanjing Medlander Medical Technology Co Annual Data
SHSE:688273 vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Nanjing Medlander Medical Technology Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanjing Medlander Medical Technology Co Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nanjing Medlander Medical Technology Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Nanjing Medlander Medical Technology Co's Interest Coverage falls into.
Nanjing Medlander Medical Technology Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanjing Medlander Medical Technology Co (SHSE:688273) has a Interest Coverage of 79.78 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Nanjing Medlander Medical Technology Co and its competitors. This is 68% below median its historical median of 250.11. Over the past decade, Nanjing Medlander Medical Technology Co's Interest Coverage has ranged from 60.45 to 817.36. According to the industry distribution chart, Nanjing Medlander Medical Technology Co ranks #144 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 30.9%.
Is Nanjing Medlander Medical Technology Co's Interest Coverage too high?
Nanjing Medlander Medical Technology Co's current Interest Coverage of 79.78 is 68% below median its 10-year median of 250.11. Over the past 10 years, this metric has ranged from a low of 60.45 to a high of 817.36. The Medical Devices & Instruments industry median Interest Coverage is 15.88. Nanjing Medlander Medical Technology Co's value of 79.78 is 402.6% above this industry median. Based on the distribution chart, Nanjing Medlander Medical Technology Co ranks #144 out of 466 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Nanjing Medlander Medical Technology Co has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nanjing Medlander Medical Technology Co's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nanjing Medlander Medical Technology Co ranks #144 out of 466 companies for Interest Coverage. This puts Nanjing Medlander Medical Technology Co in the upper half of its industry. The industry median Interest Coverage is 15.88. Nanjing Medlander Medical Technology Co's value of 79.78 is 402.6% above this benchmark. Historically, Nanjing Medlander Medical Technology Co's own Interest Coverage has ranged from 60.45 to 817.36 over the past decade. While the company's 10-year median is 250.11 vs. the industry median of 15.88, Nanjing Medlander Medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nanjing Medlander Medical Technology Co's current Interest Coverage of 79.78 is 402.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Nanjing Medlander Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanjing Medlander Medical Technology Co's current Interest Coverage is 79.78, which is 68% below median its own 10-year median of 250.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanjing Medlander Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Nanjing Medlander Medical Technology Co (SHSE:688273) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥34.86, compared to a current price of ¥41.18 — trading 18.1% above its estimated fair value. The current Interest Coverage is 79.78, which is 68% below median its 10-year median of 250.11 and 402.6% above the Medical Devices & Instruments industry median of 15.88. Nanjing Medlander Medical Technology Co's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Nanjing Medlander Medical Technology Co (SHSE:688273), the current Interest Coverage is 79.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nanjing Medlander Medical Technology Co (SHSE:688273) Overvalued in 2026?
Based on GuruFocus' analysis, Nanjing Medlander Medical Technology Co stock appears to be overvalued.
The current stock price of ¥41.18 is trading 18.1% above its estimated GF Value™ of ¥34.86.
GuruFocus considers Nanjing Medlander Medical Technology Co to be Modestly Overvalued.
Key valuation signals for SHSE:688273:
Interest Coverage: 79.78 (68% below median its 10-year median of 250.11)
GF Value™: ¥34.86 vs. price of ¥41.18 (18.1% above fair value)
Industry Position: 402.6% above the Medical Devices & Instruments median (#144 of 466)
No single metric tells the full story. See the SHSE:688273 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nanjing Medlander Medical Technology Co Business Description
Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales, and service of related products in the field of pelvic floor and postpartum rehabilitation. Its products mainly include: biostimulation feedback instrument, color ultrasound diagnosis and evaluation system, magnetic stimulator, high-frequency evaluation electrocautery instrument, pelvic floor training instrument, portable postpartum recovery instrument, home pelvic floor rehabilitation therapy instrument, etc., which are widely used in obstetrics and gynecology, pelvic floor rehabilitation center, urology, anorectal department and other hospital departments.
81GF Score
Get the complete analysis for SHSE:688273
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688273 has been successfully added to your 
